Economic evaluation of vaccination programme of 7-valent pneumococcal conjugate vaccine to the birth cohort in Japan
| Project/Area Number |
22590579
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Public health/Health science
|
|---|
| Research Institution | University of Tsukuba |
|---|
Principal Investigator |
OKUBO Ichiro 筑波大学, 医学医療系, 教授 (40323307)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
HOSHI Shu-ling 筑波大学, 医学医療系, 研究員 (90506320)
|
|---|
| Project Period (FY) |
2010 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
Fiscal Year 2012: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2011: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Keywords | 予防接種 / ワクチン / 肺炎球菌 / 費用効果分析 / 経済評価 / 費用分析効果 / 乳幼児 |
|---|
| Research Abstract |
This study aims to appraise the 'value for money' of PCV-7 vaccination programfor the birth cohort in Japan. We conducted a cost-effectiveness analysis with Markov model and calculated incremental cost-effectiveness ratio (ICER) of launching such program as a public health one. We found that ICERs in QALY were about \7,000,000 from the perspective of payers. By adopting WHO's classification that an intervention is 'cost-effective' if ICER (in QALY) is between 1 and 3 times of GDP as a criterion, PCV-7 vaccination program in Japan is concluded as "cost-effective.
|
Report
(4 results)
Research Products
(2 results)
